Monthly Archives: April 2010

Smith Electric Vehicles gets $22M more from the U.S. Department of Energy

Smith Electric Vehicles U.S. Corp. is getting $32 million in federal money to help develop future all-electric vehicles and to reimburse customers participating in a study of how the vehicles operate. ... Read More

Sensient plans $16M expansion in St. Louis

Sensient Technologies Corp. of Milwaukee said it plans to invest $16 million at its Color Group headquarters in St. Louis. Sensient will build an additional 25,000-square-foot facility dedicated to natural colors ... Read More

Sanofi expands diabetes efforts

French drug giant Sanofi-Aventis Thursday said it will further expand its diabetes business with an exclusive worldwide licensing deal with CureDM Group Holdings LLC for the U.S.-based biotech’s experimental treatment Pancreate. ... Read More

Renault, Nissan, Daimler join to manufacture electric cars

A new partnership aimed at saving billions of dollars and accelerating sales of pollution-light electric cars was created by Renault, Nissan and Daimler, the companies announced on April 7. The companies ... Read More

Qwest, CenturyTel to merge

CenturyTel Inc. agreed Thursday to buy Qwest Comunications International Inc. in an all-stock deal valuing Qwest at about $10.6 billion—one of the biggest U.S. telecommunications deals in years. The merger will ... Read More

President Obama to visit POET plant

President Barack Obama will visit POET Biorefining – Macon, Mo. on Wednesday, April 28, as part of his “White House to Main Street Tour” through Missouri, Iowa and Illinois, the White ... Read More

Plant center signals shift in research

Conditions were too soggy yesterday to break ground on a new plant research center at the actual site, but rain didn’t dampen the enthusiasm of more than 200 people who gathered ... Read More

Novartis receives FDA approval for Zortress

The US Food and Drug Administration (FDA) has approved Zortress oral tablets for the prevention of rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. Zortress is to be ... Read More

Missouri Biotech Featured in fDi Magazine

Missouri has established itself as a leader in life sciences and biotechnology – boasting of the world’s leading R&D centres in this field, writes Karen E Thuermer. Located in the US’s ... Read More

Medtronic to buy ATS Medical for $315.2M

Medical device company Medtronic Inc. said Thursday it has agreed to buy heart device maker ATS Medical Inc. for $315.2 million in cash, expanding its products for cardiac surgery. Medtronic’s offer ... Read More